Resmed (RMD) Total Debt (2010 - 2026)
Resmed's (RMD) quarterly Total Debt came in at $919.3 million in Q2 2026, up 35.55% on a YoY basis from $678.2 million in Q2 2025, and down 0.51% quarter-over-quarter from $924.0 million in Q1 2026.
Analysis
Resmed (RMD) Total Debt (2010 - 2026) Analysis & Trends
Resmed (RMD) has reported Total Debt for 17 consecutive years, with $919.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt rose 35.55% year-over-year to $919.3 million; the trailing twelve-month figure through Jun 2026 stood at $919.3 million (up 35.55% YoY), and the FY2026 full-year result was $919.3 million, up 35.55% from the prior year.
- Total Debt retreated to $919.3 million in Q2 2026 per RMD's latest filing, from $924.0 million in the prior quarter.
- Across five years, Total Debt topped out at $1.8 billion in Q4 2022 and bottomed at $678.2 million in Q2 2025.
- Historically, Total Debt has averaged $994.9 million across 5 years, with a median of $921.5 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Total Debt surged 161.64% in 2022, then slumped 50.58% in 2024.
- Over 5 years, Total Debt stood at $1.8 billion in 2022, then plunged by 31.7% to $1.2 billion in 2023, then slumped by 44.79% to $682.7 million in 2024, then surged by 35.31% to $923.7 million in 2025, then dropped by 0.48% to $919.3 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $919.3 million, $924.0 million, and $923.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 28.15 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 14.94 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 12.62 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 919.32 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 4.15 Bn |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 2.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 919.32 Mn |
| Mar 31, 2026 | 924.02 Mn |
| Dec 31, 2025 | 923.74 Mn |
| Sep 30, 2025 | 928.46 Mn |
| Jun 30, 2025 | 678.19 Mn |
| Mar 31, 2025 | 682.94 Mn |
| Dec 31, 2024 | 682.67 Mn |
| Sep 30, 2024 | 687.37 Mn |
| Jun 30, 2024 | 717.11 Mn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.45 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.81 Bn |
| Sep 30, 2022 | 805.25 Mn |
| Jun 30, 2022 | 785.16 Mn |
| Mar 31, 2022 | 692.67 Mn |
| Dec 31, 2021 | 691.98 Mn |
| Sep 30, 2021 | 817.67 Mn |